FLEXTEND
Report
- Report Number
- 2124215-2008-33545
- Event Type
- Injury
- Date Received
- May 8, 2008
- Date of Event
- February 15, 2008
- Report Date
- October 20, 2011
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVN
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- LAY USER/PATIENT
Narratives
UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. THE COMPLETE LEAD WAS RETURNED, WITH DRIED BLOOD NOTED IN THE LUMEN OF THE LEAD AND TERMINAL PIN OPENING. RESISTANCE AND PRESSURE TESTS WERE COMPLETED TO ASSESS LEAD ELECTRICAL PERFORMANCE AND INSULATION INTEGRITY. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. MICROSCOPIC INSPECTIONS OF THE TERMINAL PIN ASSEMBLY, LEAD BODY, AND ELECTRODE TIP FOUND NO ANOMALIES. LABORATORY TESTING WAS UNABLE TO REPRODUCE THE REPORTED CLINICAL OBSERVATIONS AND DETAILED ANALYSIS DID NOT REVEAL ANY ABNORMALITIES.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT 3 YEARS AGO, THIS RIGHT ATRIAL (RA) LEAD WAS SURGICALLY ABANDONED DUE TO INAPPROPRIATE ATRIAL PACING DUE TO ATRIAL UNDERSENSING, AS WELL AS HIGH IMPEDANCE MEASUREMENTS GREATER THAN 2000 OHMS. NO ADVERSE PATIENT EFFECTS WERE REPORTED. RECENTLY, THIS LEAD WAS EXPLANTED DURING AN UNRELATED PROCEDURE AND RETURNED TO BOSTON SCIENTIFIC FOR ANALYSIS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | FLEXTEND | IMPLANTABLE LEAD | NVN | CPI - DEL CARIBE | 4087 | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 75 YR | Hospitalization| L| O| R | THE DEVICE (B)(4) WAS IMPLANTED| THE DEVICE 4088/154158 WAS IMPLANTED 22-APR-2003| THE DEVICE (B)(4) WAS IMPLANTED| THE DEVICE 1294/101234 WAS IMPLANTED 22-APR-2003 |